Delivery Order SPE2DB20D1100-SPE2DB25FA0D9
Award Date
1/13/25
Potential Completion Date
1/14/25
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,810.68 Firm Fixed Price Delivery Order contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of December 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,191.29 firm fixed-price delivery order is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL14D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,483.36 Firm Fixed Price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract has a completion date of January 5, 2024 and was awarded on January 4, 2024. This delivery order is part of a larger...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FV41D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,398.72 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has an ultimate completion date of September 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,603.60, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of January 22, 2025. This award is a part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,177.16, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order, with a completion date of February 21, 2025. The contract has no set-aside designation, indicating it was competed under open...
This federal contract award, valued at $101,168.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a Firm Fixed Price pricing type and an ultimate completion date of December 4, 2024. This award is part of a larger Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRPL6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,710.89 Firm Fixed Price Delivery Order contract covers the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract has an ultimate completion date of July 9, 2024. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,826.42 Firm Fixed Price delivery order provides the DLA with 4566444751 TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has an ultimate completion date of November 18, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FM5S4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,769.95 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has a performance period through February 5, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...